Abstract 4147872: Self-Expanding versus Balloon-Expandable Transcatheter Aortic Valve Implantation in Patients With Small Aortic Annulus: An Updated Systematic Review And Meta-Analysis

Introduction: Both self-expanding (SEV) and balloon-expandable (BEV) valves are used in transcatheter aortic valve implantation (TAVI) for patients with severe aortic stenosis (AS) and small aortic annulus (SAA). This updated meta-analysis compares the efficacy and safety of SEV versus BEV in TAVI for these patients. Hypothesis: This study investigates whether SEV valves are hemodynamically and clinically superior to BEV valves in patients with small aortic annulus. Methods: PubMed, SCOPUS, and Cochrane Central databases were systematically searched for randomized and observational studies comparing SEV and BEV in TAVI for SAA patients. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random-effects model for clinical outcomes (all-cause mortality, stroke, permanent pacemaker implantation [PPI]) and hemodynamic parameters (mean gradient [MG], indexed effective orifice area [iEOA], moderate to severe prosthesis-patient mismatch [PPM], and paravalvular leak [PVL]). Results: A total of 21 studies involving 6,515 patients (58.4% treated with SEV) were included. SEV valves were associated with lower all-cause mortality (OR 0.75; 95% CI 0.60-0.95; p=0.014), lower MG (OR -4.44; 95% CI -5.48-3.39; p<0.01), higher iEOA (OR 0.23; 95% CI 0.13-0.23; p<0.01), and less moderate to severe PPM (OR 0.31; 95% CI 0.22-0.45; p<0.001). However, SEV valves had higher rates of PPI (OR 1.35; 95% CI 1.01-1.80; p=0.042) and PVL (OR 2.69; 95% CI 1.58-4.57; p<0.001). Stroke rates were not significantly different between the groups. Conclusion: In patients with severe AS and SAA, TAVI with SEV valves showed better outcomes in all-cause mortality, MG, iEOA, and moderate to severe PPM. However, BEV valves had advantages in lower PPI and PVL rates. These findings should be interpreted cautiously due to the predominance of observational studies and varying valve types and generations used.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4147872
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4147872: Self-Expanding versus Balloon-Expandable Transcatheter Aortic Valve Implantation in Patients With Small Aortic Annulus: An Updated Systematic Review And Meta-Analysis

Nicole dos Santos Pimenta, Fernanda Valeriano Zamora, João Pedro Costa Esteves Almuinha Salles, David Curi et al.
Circulation
Cardiac Valve Diseases and Treatments
article

Abstract 4147872: Self-Expanding versus Balloon-Expandable Transcatheter Aortic Valve Implantation in Patients With Small Aortic Annulus: An Updated Systematic Review And Meta-Analysis

Nicole dos Santos Pimenta, Fernanda Valeriano Zamora, João Pedro Costa Esteves Almuinha Salles, David Curi, Filippe Barcellos Filippini, Ana Clara Felix de Farias Santos, Lorhayne Kerley Capuchinho Scalioni Galvão, Bárbara Mariz Ferreira Passos
article en

Abstract

Introduction: Both self-expanding (SEV) and balloon-expandable (BEV) valves are used in transcatheter aortic valve implantation (TAVI) for patients with severe aortic stenosis (AS) and small aortic annulus (SAA). This updated meta-analysis compares the efficacy and safety of SEV versus BEV in TAVI for these patients. Hypothesis: This study investigates whether SEV valves are hemodynamically and clinically superior to BEV valves in patients with small aortic annulus. Methods: PubMed, SCOPUS, and Cochrane Central databases were systematically searched for randomized and observational studies comparing SEV and BEV in TAVI for SAA patients. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a random-effects model for clinical outcomes (all-cause mortality, stroke, permanent pacemaker implantation [PPI]) and hemodynamic parameters (mean gradient [MG], indexed effective orifice area [iEOA], moderate to severe prosthesis-patient mismatch [PPM], and paravalvular leak [PVL]). Results: A total of 21 studies involving 6,515 patients (58.4% treated with SEV) were included. SEV valves were associated with lower all-cause mortality (OR 0.75; 95% CI 0.60-0.95; p=0.014), lower MG (OR -4.44; 95% CI -5.48-3.39; p<0.01), higher iEOA (OR 0.23; 95% CI 0.13-0.23; p<0.01), and less moderate to severe PPM (OR 0.31; 95% CI 0.22-0.45; p<0.001). However, SEV valves had higher rates of PPI (OR 1.35; 95% CI 1.01-1.80; p=0.042) and PVL (OR 2.69; 95% CI 1.58-4.57; p<0.001). Stroke rates were not significantly different between the groups. Conclusion: In patients with severe AS and SAA, TAVI with SEV valves showed better outcomes in all-cause mortality, MG, iEOA, and moderate to severe PPM. However, BEV valves had advantages in lower PPI and PVL rates. These findings should be interpreted cautiously due to the predominance of observational studies and varying valve types and generations used.

CirculationVol. 150(Suppl_1)
Universidade Federal do Rio de Janeiro (BR), Universidade de São Paulo (BR), Universidade Cidade de São Paulo (BR), Associação Fundo de Incentivo à Pesquisa (BR), Universidade Federal do Estado do Rio de Janeiro (BR)
Good health and well-being
Openalex Percentile: Top 62%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.